Meet the Oryn Team

Experienced Scientific and Business Team

Oryn is led by an experienced team comprising strength in both science and business. The growing team includes the company founders and the scientists that have led years of research in Orynotides and an entirely new class of therapeutics. They also have experienced business leaders helping to advance the company’s vision and the benefit of a world-class scientific advisory board.

Management Team

Robert Erwin
Chairman & Chief Executive Officer

One of the founders of Oryn Therapeutics, Robert Erwin serves as Chairman and CEO. He has previously served as CEO and as president of two publicly traded biotechnology companies and on boards of several private biotechnology companies.

James Mullaney
Chief Financial and Chief Operating Officer

Richard Selsted
Chief Business Officer, Director

Charles Gluchowski, Ph.D.
Vice President, Research

Michael Selsted, M.D., Ph.D.
Chief Scientific Officer

Percio S. Gulko, M.D.
Chief Medical Officer

Scientific Advisory Board

Scott Filler, M.D.

Scott Filler is Professor of Medicine at David Geffen School of Medicine and Chief of the Division of Infectious Diseases at Harbor-UCLA Medical Center. He is internationally renowned for his research on the mechanisms by which fungal pathogens invade and damage human cells, causing life-threatening infections.

Mike Gresser, Ph.D.

Paul McCray, Jr., M.D.

Charles L Bevins, M.D., Ph.D.

Board of Directors

Mark Armenante
Founder and Director of Vlocity

Mark Armenante is a Co-Founder and Board Member at Vlocity, which was founded in 2014 and sold to SalesForce in 2020. He also co-founded and serves as a Board Member at Veeva Systems Inc., which became public in 2013 and now has a market cap of $39 billion. Mark is the owner and principal at Verve Wines.

Young A. Sohn
Founder and Director of Vlocity

Robert Erwin

Richard Selsted
Chief Business Officer